A detailed history of Arthur M. Cohen & Associates, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Arthur M. Cohen & Associates, LLC holds 4,458 shares of DXCM stock, worth $357,709. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,458
Previous 10,478 57.45%
Holding current value
$357,709
Previous $1.19 Million 74.89%
% of portfolio
0.05%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$64.0 - $116.06 $385,280 - $698,681
-6,020 Reduced 57.45%
4,458 $298,000
Q2 2024

Jul 29, 2024

BUY
$110.31 - $140.45 $70,157 - $89,326
636 Added 6.46%
10,478 $1.19 Million
Q1 2024

Apr 22, 2024

SELL
$114.22 - $140.1 $190,747 - $233,967
-1,670 Reduced 14.51%
9,842 $1.37 Million
Q4 2023

Jan 10, 2024

SELL
$75.49 - $124.16 $25,666 - $42,214
-340 Reduced 2.87%
11,512 $1.43 Million
Q3 2023

Oct 20, 2023

SELL
$86.06 - $137.93 $24,096 - $38,620
-280 Reduced 2.31%
11,852 $1.11 Million
Q2 2023

Jul 19, 2023

SELL
$112.47 - $130.98 $39,364 - $45,843
-350 Reduced 2.8%
12,132 $1.56 Million
Q1 2023

Apr 24, 2023

SELL
$104.0 - $122.92 $37,440 - $44,251
-360 Reduced 2.8%
12,482 $1.45 Million
Q4 2022

Jan 17, 2023

SELL
$84.98 - $122.67 $33,142 - $47,841
-390 Reduced 2.95%
12,842 $0
Q3 2022

Oct 21, 2022

BUY
$76.35 - $94.18 $127,504 - $157,280
1,670 Added 14.44%
13,232 $1.07 Million
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $552,010 - $1.08 Million
8,119 Added 235.81%
11,562 $862,000
Q1 2022

May 03, 2022

BUY
$94.08 - $130.2 $30,764 - $42,575
327 Added 10.49%
3,443 $1.76 Million
Q4 2021

Jan 24, 2022

BUY
$129.87 - $162.82 $2,597 - $3,256
20 Added 0.65%
3,116 $1.67 Million
Q3 2021

Oct 08, 2021

BUY
$106.71 - $143.18 $330,374 - $443,285
3,096 New
3,096 $1.69 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Arthur M. Cohen & Associates, LLC Portfolio

Follow Arthur M. Cohen & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.